Anti-PD-L1 therapy reduced the proportions of intratumoral PD-L1+ lymphoid and myeloid cell populations and induced tumor vascular normalization in a CD8+ T cell dependent manner, while CD4+ T cells impeded these effects. Here, CD8A is linked to neoplasm.